Pediatric Hematology/Oncology

Vascular Neurology

Questions discussed in this category

How do you approach managing depression symptoms in patients who have had repeated high risk of bleeding?

When do you determine SSRI therapy is unsafe to pursue in such situations?

Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?

Labs with normal PT, but prolonged PTT (47 sec; ULN 40 sec) that does not correct on immediate mix. Lupus anticoagulant negative (DRVVT and hexagonal ...

1 Answer available

Would you recommend anticoagulation in a pediatric patient with metastases in a dural venous sinus?

1 Answer available

What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?

When would you stop anticoagulation?

4 Answers available

Do you screen children with sickle cell disease for silent cerebral infarcts?

1 Answer available

When do you consider testing with stroke gene panels in young stroke patients?

2 Answers available

Do you screen adults in your practice with sickle cell disease for silent cerebral infarcts?

The ASH 2020 guidelines have "recommended that adults with HbSS or HbSβ0 thalassemia be screened at least once for silent cerebral infarcts even ...

1 Answer available

Papers discussed in this category

American journal of hematology, 2023 May 12

An integrated therapeutic approach to sickle cell disease management beyond infancy.

The New England journal of medicine, 2014 Aug 21

More blood for sickle cell anemia?

Blood advances, 2020 Jun 23

American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Pharmacological research, 2016 Aug 10

Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies.

The Annals of pharmacotherapy, 2018 Aug 06

Clinical Management of Bleeding Risk With Antidepressants.

Stroke, 2023 Sep 07

Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.

Stroke, 2024 Jan 29

Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association.

Pediatric Hematology/Oncology

Vascular Neurology

Questions discussed in this category

Papers discussed in this category

Related Topics in Pediatric Hematology/Oncology